SHR-1703 Injection

DRUG2 trials

Sponsors

Guangdong Hengrui Pharmaceutical Co., Ltd

Conditions

Asthma With Eosinophilic PhenotypeEosinophilic Asthma Patients

Phase 1

A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants

Not yet recruitingNCT07701239

Guangdong Hengrui Pharmaceutical Co., LtdAsthma With Eosinophilic Phenotype

Start: 2026-07-01End: 2027-04-01Target: 84Updated: 2026-07-14

Phase 2

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

RecruitingNCT06441812

Guangdong Hengrui Pharmaceutical Co., LtdEosinophilic Asthma Patients

Start: 2024-07-19End: 2028-09-30Target: 200Updated: 2025-12-18